{"schema_version":"secwatch.filing_event.v1","accession":"0001434647-26-000009","form_type":"8-K","ticker":"ZVRA","cik":"0001434647","company_name":"ZEVRA THERAPEUTICS, INC.","filed_at":"2026-03-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.074900+00:00","generated_at":"2026-05-15T17:36:05.907981+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Zevra reports Q4 net revenue $34.1M, net income $12.2M; appoints Justin Renz as CFO","bullets":["Q4 2025 net revenue $34.1M (+31% QoQ); net income $12.2M ($0.19 diluted EPS) vs. $(35.7)M loss in Q4 2024.","FY 2025 net revenue $106.5M (MIPLYFFA $87.4M); net income $83.2M ($1.35 diluted EPS) vs. $(105.5)M loss in FY 2024.","MIPLYFFA: 24 new prescription enrollment forms in Q4; 52 in 2025; 161 since launch; EU MAA under EMA review, 120-day questions received.","Justin Renz appointed CFO effective March 9, 2026; base salary $520k, 45% target bonus, option grant of 300k shares vesting over 4 years.","Cash, cash equivalents and securities $238.9M at year-end; 56.9M common shares outstanding."],"urls":{"canonical":"https://secwatch.observer/filing/0001434647-26-000009","json":"https://secwatch.observer/filing/0001434647-26-000009.json","markdown":"https://secwatch.observer/filing/0001434647-26-000009.md","text":"https://secwatch.observer/filing/0001434647-26-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434647/000143464726000009/0001434647-26-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434647/000143464726000009/zvra-20260304.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T17:36:05.907981+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}